LFG
AVXL icon

Larson Financial Group’s Anavex Life Sciences AVXL Stock Holding History

Larson Financial Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.89K Sell
614
-625
-50% -$2.71K ﹤0.01% 2973
2025
Q4 		$4.41K Buy
1,239
+650
+110% +$3.98K ﹤0.01% 2507
2025
Q3 		$5.24K Buy
589
+39
+7% +$396 ﹤0.01% 2338
2025
Q2 		$5.07K Sell
550
-19
-3% -$162 ﹤0.01% 2064
2025
Q1 		$4.88K Sell
569
-8
-1% -$76 ﹤0.01% 1888
2024
Q4 		$6.2K Sell
577
-638
-53% -$4.91K ﹤0.01% 1615
2024
Q3 		$6.9K Hold
1,215
– – ﹤0.01% 1604
2024
Q2 		$5.13K Hold
1,215
– – ﹤0.01% 1440
2024
Q1 		$6.18K Buy
1,215
+205
+20% +$1.15K ﹤0.01% 1150
2023
Q4 		$9.4K Hold
1,010
– – ﹤0.01% 1033
2023
Q3 		$6.62K Hold
1,010
– – ﹤0.01% 1107
2023
Q2 		$8.21K Hold
1,010
– – ﹤0.01% 992
2023
Q1 		$8.66K Buy
1,010
+15
+2% +$150 ﹤0.01% 963
2022
Q4 		$9.21K Buy
995
+445
+81% +$4.75K ﹤0.01% 884
2022
Q3 		$6K Hold
550
– – ﹤0.01% 908
2022
Q2 		$6K Hold
550
– – ﹤0.01% 817
2022
Q1 		$7K Hold
550
– – ﹤0.01% 722
2021
Q4 		$10K Hold
550
– – ﹤0.01% 679
2021
Q3 		$10K Hold
550
– – ﹤0.01% 585
2021
Q2 		$13K Hold
550
– – ﹤0.01% 507
2021
Q1 		$8K Hold
550
– – ﹤0.01% 578
2020
Q4 		$3K Hold
550
– – ﹤0.01% 593
2020
Q3 		$3K Hold
550
– – ﹤0.01% 560
2020
Q2 		$3K Hold
550
– – ﹤0.01% 520
2020
Q1 		$2K Hold
550
– – ﹤0.01% 421
2019
Q4 		$1K Hold
550
– – ﹤0.01% 486
2019
Q3 		$2K Hold
550
– – ﹤0.01% 426
2019
Q2 		$2K Hold
550
– – ﹤0.01% 377
2019
Q1 		$2K Hold
550
– – ﹤0.01% 368
2018
Q4 		$1K Buy
+550
New +$1.25K ﹤0.01% 388

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Larson Financial Group's AVXL Position: Q1 2026 in Review

Larson Financial Group reduced its Anavex Life Sciences (AVXL) stake by 50% in Q1 2026, selling an estimated $2.71K and leaving 614 shares worth $1.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2973.

Larson Financial Group first reported a position in AVXL in Q4 2018 and has held it in 30 quarters since. The position peaked at $13K in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Larson Financial Group held 614 shares of Anavex Life Sciences worth $1.89K as of Q1 2026.
  • Larson Financial Group sold 625 Anavex Life Sciences shares in Q1 2026, an estimated $2.71K.
  • Anavex Life Sciences made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2973 holding.
  • Larson Financial Group first reported a position in Anavex Life Sciences in Q4 2018 and has held it in 30 quarters since.
  • Larson Financial Group's Anavex Life Sciences position peaked at $13K in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.